Product Information
FUROSEMIDE 40 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0291 per EA under NDC 00054429931. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 10, 1983. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054429931
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FUROSEMIDEApproval Type
New Drug (NDA)
FDA Application
NDA018823FDA Approved
11/10/1983
TE Code
AB
On Market Since
11/10/1983
Pharmacological Classes
Price Statistics
The NADAC for FUROSEMIDE 40 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 160.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0291 per EA |
|---|---|
| All-time high | $0.0383 (Jan 10, 2018) |
| All-time low | $0.0100 (Jun 18, 2014) |
| 52-week high | $0.0326 |
| 52-week low | $0.0291 |
| Median price | $0.0309 |
| Average price | $0.0264 |
| Largest weekly change | +55.3% (Oct 18, 2017) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Furosemide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Loop Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FUROSEMIDE 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 40 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0291 per EA (NDC 00054429931), effective Sep 30, 2026.
How has the price of FUROSEMIDE 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for FUROSEMIDE 40 MG TABLET has risen 160.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FUROSEMIDE 40 MG TABLET?
Since Nov 28, 2013, the NADAC for FUROSEMIDE 40 MG TABLET has ranged from a low of $0.0100 (Jun 18, 2014) to a high of $0.0383 (Jan 10, 2018), with a median of $0.0309 per EA.
Are there cheaper alternatives to FUROSEMIDE 40 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FUROSEMIDE 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FUROSEMIDE 40 MG TABLET?
FUROSEMIDE 40 MG TABLET (NDC 00054429931) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.